These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 18477489

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Hormonal contraception and the risk of HIV acquisition.
    Morrison CS, Richardson BA, Mmiro F, Chipato T, Celentano DD, Luoto J, Mugerwa R, Padian N, Rugpao S, Brown JM, Cornelisse P, Salata RA, Hormonal Contraception and the Risk of HIV Acquisition (HC-HIV) Study Group.
    AIDS; 2007 Jan 02; 21(1):85-95. PubMed ID: 17148972
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Initiation and continuation rates seen in 2-year experience with Same Day injections of DMPA.
    Nelson AL, Katz T.
    Contraception; 2007 Feb 02; 75(2):84-7. PubMed ID: 17241834
    [Abstract] [Full Text] [Related]

  • 6. Facts about injectable contraceptives: memorandum from a WHO meeting.
    Bull World Health Organ; 1982 Feb 02; 60(2):199-210. PubMed ID: 6213318
    [Abstract] [Full Text] [Related]

  • 7. Implanon as a contraceptive choice for teenage mothers: a comparison of contraceptive choices, acceptability and repeat pregnancy.
    Lewis LN, Doherty DA, Hickey M, Skinner SR.
    Contraception; 2010 May 02; 81(5):421-6. PubMed ID: 20399949
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Continuation of subcutaneous or intramuscular injectable contraception when administered by facility-based and community health workers: findings from a prospective cohort study in Burkina Faso and Uganda.
    MacLachlan E, Atuyambe LM, Millogo T, Guiella G, Yaro S, Kasasa S, Bukenya J, Nyabigambo A, Mubiru F, Tumusiime J, Onadja Y, Zan LM, Goeum/Sanon C, Kouanda S, Namagembe A.
    Contraception; 2018 Nov 02; 98(5):423-429. PubMed ID: 30125558
    [Abstract] [Full Text] [Related]

  • 11. Longitudinal study of depot medroxyprogesterone acetate (Depo-Provera) effects on bone health in adolescents: study design, population characteristics and baseline bone mineral density.
    Johnson CC, Burkman RT, Gold MA, Brown RT, Harel Z, Bruner A, Stager M, Bachrach LK, Hertweck SP, Nelson AL, Nelson DA, Coupey SM, McLeod A, Bone HG.
    Contraception; 2008 Apr 02; 77(4):239-48. PubMed ID: 18342646
    [Abstract] [Full Text] [Related]

  • 12. Change in bone mineral density among adolescent women using and discontinuing depot medroxyprogesterone acetate contraception.
    Scholes D, LaCroix AZ, Ichikawa LE, Barlow WE, Ott SM.
    Arch Pediatr Adolesc Med; 2005 Feb 02; 159(2):139-44. PubMed ID: 15699307
    [Abstract] [Full Text] [Related]

  • 13. Continuation of injectable contraception when self-injected vs. administered by a facility-based health worker: a nonrandomized, prospective cohort study in Uganda.
    Cover J, Namagembe A, Tumusiime J, Nsangi D, Lim J, Nakiganda-Busiku D.
    Contraception; 2018 Nov 02; 98(5):383-388. PubMed ID: 29654751
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [An introductory clinical trial of three-monthly injectable contraceptive-depot medroxyprogesterone acetate].
    Shao Q, Jiang H, Fu W.
    Zhonghua Fu Chan Ke Za Zhi; 1999 Jan 02; 34(1):36-9. PubMed ID: 11263172
    [Abstract] [Full Text] [Related]

  • 16. Researcher explains status of Depo Provera. [Answer to question of Marienetta Blackwell].
    Greenspan A.
    Contracept Technol Update; 1981 Mar 02; 2(3):35-6. PubMed ID: 12337540
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Subcutaneous DMPA vs. intramuscular DMPA: a 2-year randomized study of contraceptive efficacy and bone mineral density.
    Kaunitz AM, Darney PD, Ross D, Wolter KD, Speroff L.
    Contraception; 2009 Jul 02; 80(1):7-17. PubMed ID: 19501210
    [Abstract] [Full Text] [Related]

  • 19. Demographic analysis of post-abortive and interval-administered hormonal contraceptive methods.
    Ertopçu K, Inal MM, Ozelmas I.
    Eur J Contracept Reprod Health Care; 2005 Mar 02; 10(1):1-5. PubMed ID: 16036290
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.